Core Labs (CLB) Tops Q1 EPS by 1c; Guides Q2, FY11
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/31/2026
- Wall Street closes sharply lower as AI cash burn fears spark tech selloff
- Amazon burns cash, Intel flags weak PC demand as AI boom's costs ripple across markets
- Bitcoin, cryptocurrency prices fall after Binance reports security issue
- Higher yields now hurting AI stock bull as bond markets police capex: BofA
- Oil jumps 2%, settles at 6-month highs on fears of escalation in Iran
Tweet
Share
E-mailGet Alerts CLB Hot Sheet
Join SI Premium – FREE
Core Laboratories NV (NYSE: CLB) reported Q1 EPS of $0.77, $0.01 better than the analyst estimate of $0.76. Revenue for the quarter came in at $206.73 million versus the consensus estimate of $202.34 million.
Sees Q2 sales of $215 - $220 million, versus $218.7 million. Sees EPS of 84-88c, vs. the consensus of 88c.
Sees FY11 sales of $890-$910 million, which compares to the Street estimate of $894.2 million. Sees EPS of $3.55-$3.60, vs. the consensus of $3.63.
Sees Q2 sales of $215 - $220 million, versus $218.7 million. Sees EPS of 84-88c, vs. the consensus of 88c.
Sees FY11 sales of $890-$910 million, which compares to the Street estimate of $894.2 million. Sees EPS of $3.55-$3.60, vs. the consensus of $3.63.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Verra Mobility (VRRM) Tops Q3 EPS by 10c ; Offers Guidance
- BrightSpring Health Services, Inc. (BTSG) Tops Q3 EPS by 34c ; Offers Guidance
- Aurinia Pharmaceuticals (AUPH) Misses Q3 EPS by 1c, Misses on Revenue; Offers FY26 Revenue Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
